MTD:NYE-Mettler-Toledo International Inc (USD)

COMMON STOCK | Diagnostics & Research |

Last Closing

USD 1184.34

Change

0.00 (0.00)%

Market Cap

N/A

Volume

0.16M

Analyst Target

USD 865.00
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-06-07 )

Largest Industry Peers for Diagnostics & Research

Symbol Name Price(Change) Market Cap
DHR Danaher Corporation

N/A

USD 140.35B
A Agilent Technologies Inc

N/A

USD 32.44B
IQV IQVIA Holdings Inc

N/A

USD 24.71B
LH Laboratory Corporation of Amer..

N/A

USD 20.88B
DGX Quest Diagnostics Incorporated

N/A

USD 19.12B
QGEN Qiagen NV

N/A

USD 9.05B
CRL Charles River Laboratories

N/A

USD 6.92B
ENZ Enzo Biochem Inc

N/A

USD 0.02B
TMO Thermo Fisher Scientific Inc

N/A

N/A
WAT Waters Corporation

N/A

N/A

ETFs Containing MTD

MCSE Martin Currie Sustainable.. 5.12 % 0.00 %

N/A

N/A
EPRE 4.58 % 0.00 %

N/A

N/A
IBB iShares Biotechnology ETF 2.80 % 0.47 %

N/A

USD 5.11B
ASRP:XETRA BNP Paribas Easy ECPI Glo.. 2.39 % 0.00 %

N/A

N/A
XMLC:F L&G Clean Water UCITS ETF 2.27 % 0.00 %

N/A

N/A
XLVE:CA 1.82 % 0.00 %

N/A

N/A
HECO SPDR Galaxy Hedged Digita.. 0.00 % 0.95 %

N/A

N/A
QRI:CA 0.00 % 1.06 %

N/A

N/A
YXM.B:CA 0.00 % 0.69 %

N/A

N/A
MJJ 0.00 % 0.00 %

N/A

N/A
MJO 0.00 % 0.00 %

N/A

N/A
DWEQ 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Diagnostics & Research) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -3.21% 75% C 34% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -3.21% 75% C 32% F
Trailing 12 Months  
Capital Gain -17.67% 50% F 13% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -17.67% 50% F 12% F
Trailing 5 Years  
Capital Gain 39.55% 73% C 61% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 39.55% 73% C 50% F
Average Annual (5 Year Horizon)  
Capital Gain 7.10% 83% B 64% D
Dividend Return 7.10% 83% B 56% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 24.53% 67% D+ 38% F
Risk Adjusted Return 28.94% 75% C 48% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike